Provided by Tiger Fintech (Singapore) Pte. Ltd.

CSTONE PHARMA-B

7.170
-0.350-4.65%
Volume:9.12M
Turnover:65.74M
Market Cap:10.50B
PE:-91.83
High:7.610
Open:7.610
Low:7.070
Close:7.520
Loading ...

CStone Pharmaceuticals Announces Upcoming Board Meeting to Review Interim Results and Potential Interim Dividend

Reuters
·
04 Aug

When Will CStone Pharmaceuticals (HKG:2616) Breakeven?

Simply Wall St.
·
29 Jul

CStone Pharmaceuticals Announces Debut of CS2009 Clinical Data and CS5001 Trial Design at ESMO 2025

Reuters
·
28 Jul

HK Movers | Biotechnology Stocks Jump With MicroPort up 20%

Tiger Newspress
·
24 Jul

HK Movers | HK's Biotech Shares Soar. Fudan-zhangjiang Soars 22%; Akeso up 11%; CStone Pharma up 9%

Tiger Newspress
·
17 Jul

CStone Pharmaceuticals Completes Placing of 100 Million New Shares Under General Mandate at HK$4.72 Each

Reuters
·
16 Jul

CStone Pharma Receives China's Nod to Locally Manufacture Cancer Drug Gavreto

MT Newswires Live
·
10 Jul

CStone Pharmaceuticals Secures NMPA Approval for Localized Manufacturing of Gavreto (Pralsetinib) in China

Reuters
·
10 Jul

CStone Pharmaceuticals Announces HK$472 Million Private Placement of New Shares Under General Mandate

Reuters
·
09 Jul

CStone Licenses Cancer Drug Sugemalimab in EU for Over $190 Million; Shares Rise 15%

MT Newswires Live
·
08 Jul

Stock Track | CStone Pharma Soars 5.42% on $192.5 Million Licensing Deal for Sugemalimab in Europe

Stock Track
·
08 Jul

BRIEF-Cstone Pharmaceuticals Signs Exclusive License Agreement With Istituto Gentili

Reuters
·
08 Jul

High Growth Tech Stocks In Asia To Watch This July 2025

Simply Wall St.
·
07 Jul

CStone Reports Encouraging Phase 3 Data for Liver Cancer Drug; Shares Gain 2%

MT Newswires Live
·
07 Jul

What CStone Pharmaceuticals' (HKG:2616) 33% Share Price Gain Is Not Telling You

Simply Wall St.
·
07 Jul

CStone Pharmaceuticals Announces Promising Update on Global Phase III Trial of Nofazinlimab for Hepatocellular Carcinoma

Reuters
·
04 Jul

CStone Pharmaceuticals Announces New Clinical Trials for Innovative Bispecific Antibodies Targeting Autoimmune Diseases

Reuters
·
03 Jul

CStone Pharmaceuticals Conducted Annual General Meeting

Reuters
·
25 Jun

CStone Pharmaceuticals Announces Publication of Long-Term Survival Data from GEMSTONE-302 Trial in The Lancet Oncology

Reuters
·
19 Jun

CStone Pharmaceuticals CEO Boosts Shareholding

MT Newswires Live
·
09 Apr